Mario Martínez Soldevilla

CD28 Aptamers as Powerful Immune Response Modulators

Fernando Pastor, Mario Martínez Soldevilla, Helena Villanueva et al. · Molecular Therapy — Nucleic Acids · 2013 · 125 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia

Mario Martínez Soldevilla, Helena Villanueva, Maurizio Bendandi et al. · Biomaterials · 2015 · 84 citations

Medicine, Molecular Biology, Oncology +13

MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells

Mario Martínez Soldevilla, Helena Villanueva, Noëlia Casares et al. · Oncotarget · 2016 · 66 citations · Full text

Medicine, Immunology, Oncology +17

Targeting inhibition of Foxp3 by a CD28 2′-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy

Teresa Lozano, Mario Martínez Soldevilla, Noëlia Casares et al. · Biomaterials · 2016 · 54 citations

Medicine, Immunology, Oncology +11

In Silico Aptamer Docking Studies: From a Retrospective Validation to a Prospective Case Study'TIM3 Aptamers Binding

Obdulia Rabal, Fernando Pastor, Helena Villanueva et al. · Molecular Therapy — Nucleic Acids · 2016 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17